We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




DNA-Based Droplet System Rapidly Detects Bacterial Infection in the Bloodstream

By LabMedica International staff writers
Posted on 23 Nov 2014
Print article
Image: IC 3D technology rapidly detects bacterial infection in blood samples (Photo courtesy of University of California, Irvine).
Image: IC 3D technology rapidly detects bacterial infection in blood samples (Photo courtesy of University of California, Irvine).
A new test for bacterial infection in the bloodstream is based on an innovative DNA labeling and particle counting system.

Investigators at the University of California, Irvine (USA) recently described a new technology termed "Integrated Comprehensive Droplet Digital Detection" (IC 3D) that can selectively detect bacteria directly from milliliters of diluted blood. IC 3D is a one-step, culture- and amplification-free process that provides results with single-cell level sensitivity in from ninety minutes to four hours.

The IC 3D instrument converts blood samples into billions of minute droplets. Fluorescent DNA sensor solution infused into the droplets detects those with bacterial markers, marking them with an intense fluorescent signal. Separating the samples using real-time, DNAzyme-based sensors, droplet microencapsulation, and a high-throughput 3D particle counter system minimizes the interference of other components in blood, making it possible to directly detect target bacteria without the purification typically required in conventional assays.

Using Escherichia coli as a target, the investigators demonstrated that the IC 3D system could provide absolute quantification of both stock and clinical isolates of E. coli in spiked blood within a broad range of extremely low concentration from one to 10,000 bacteria per milliliter with exceptional robustness and limit of detection in the single digit range.

“We are extremely excited about this technology because it addresses a long-standing unmet medical need in the field,” said senior author Dr. Weian Zhao, assistant professor of pharmaceutical sciences at the University of California, Irvine. “As a platform technology, it may have many applications in detecting extremely low-abundance biomarkers in other areas, such as cancers, HIV and, most notably, Ebola.”

The study was published in the November 13, 2014, online edition of the journal Nature Communications.

Related Links:

University of California, Irvine


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.